These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21964476)

  • 1. Cytotoxicity of 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT) and analogues in wild type and CYP3A4 stably transfected HepG2 cells.
    Frederick DM; Jacinto EY; Patel NN; Rushmore TH; Tchao R; Harvison PJ
    Toxicol In Vitro; 2011 Dec; 25(8):2113-9. PubMed ID: 21964476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.
    Crincoli CM; Patel NN; Tchao R; Harvison PJ
    Toxicology; 2008 Sep; 250(2-3):100-8. PubMed ID: 18621092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.
    Patel NN; Crincoli CM; Frederick DM; Tchao R; Harvison PJ
    J Appl Toxicol; 2012 Feb; 32(2):108-17. PubMed ID: 21337588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells.
    Keil AM; Frederick DM; Jacinto EY; Kennedy EL; Zauhar RJ; West NM; Tchao R; Harvison PJ
    Toxicol In Vitro; 2015 Oct; 29(7):1887-96. PubMed ID: 26193171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.
    Patel NN; Crincoli CM; Kennedy EL; Frederick DM; Tchao R; Harvison PJ
    Xenobiotica; 2008 Apr; 38(4):435-49. PubMed ID: 18340566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells.
    Jiang JZ; Yang BH; Ji LL; Yang L; Mao YC; Hu ZH; Wang ZT; Wang CH
    Toxicol In Vitro; 2017 Feb; 38():59-66. PubMed ID: 27836570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.
    Wu Q; Ning B; Xuan J; Ren Z; Guo L; Bryant MS
    Toxicol Lett; 2016 Jun; 253():55-62. PubMed ID: 27113703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.
    Zahno A; Brecht K; Morand R; Maseneni S; Török M; Lindinger PW; Krähenbühl S
    Biochem Pharmacol; 2011 Feb; 81(3):432-41. PubMed ID: 21070748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an optimized cytotoxicity assay system for CYP3A4-mediated metabolic activation via modified piggyBac transposition.
    Huang L; Zou S; Deng J; Dai T; Jiang J; Jia Y; Dai R; Xie S
    Toxicol In Vitro; 2016 Apr; 32():132-7. PubMed ID: 26706816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
    Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
    Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular toxicity of clopidogrel: mechanisms and risk factors.
    Zahno A; Bouitbir J; Maseneni S; Lindinger PW; Brecht K; Krähenbühl S
    Free Radic Biol Med; 2013 Dec; 65():208-216. PubMed ID: 23770199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.
    Ghosh C; Hossain M; Spriggs A; Ghosh A; Grant GA; Marchi N; Perucca E; Janigro D
    Epilepsia; 2015 Mar; 56(3):439-49. PubMed ID: 25656284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
    Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
    Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione- and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats.
    Kennedy EL; Tchao R; Harvison PJ
    Toxicology; 2003 Apr; 186(1-2):79-91. PubMed ID: 12604172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.
    Tolosa L; Donato MT; Pérez-Cataldo G; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2012 Dec; 26(8):1272-7. PubMed ID: 22138474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone hydroxylation in bovine liver: enzyme kinetic and inhibition study.
    Pegolo S; Giantin M; Dacasto M; Montesissa C; Capolongo F
    Xenobiotica; 2010 Apr; 40(4):255-61. PubMed ID: 20088676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
    Vignati L; Turlizzi E; Monaci S; Grossi P; Kanter Rd; Monshouwer M
    Toxicology; 2005 Dec; 216(2-3):154-67. PubMed ID: 16169652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
    Murray M; Zhang WV; Edwards RJ
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.